Clinical Trial

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

Study acronym: ProMOC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future. The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control. Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06 -> 2026-12 2026-07-22
minor Completion pushed: 2026-06 -> 2026-12 2026-07-22
Trial Details
NCT Number NCT06647472
Lead Sponsor Vejle Hospital
Collaborators: University of Aarhus
Conditions Myopia, Healthy, Orthokeratology
Enrollment 20 participants
Start Date 2024-11-15
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-21